Investors in Arvinas Inc (Symbol: ARVN) saw new options begin trading today, for the December 2025 expiration. One of the key data points that goes into the price an option buyer is willing to pay ...

In this article, we are going to take a look at where Arvinas, Inc. (NASDAQ:ARVN) stands against the other small-cap ...

On Tuesday, Arvinas Inc. (NASDAQ:ARVN) and Pfizer Inc. (NYSE:PFE) announced preliminary data from the ongoing Phase 1b portion of the TACTIVE-U sub-study of vepdegestrant in combination with ...

In trading on Thursday, shares of Arvinas Inc (Symbol: ARVN) entered into oversold territory, hitting an RSI reading of 28.8, after changing hands as low as $17.85 per share. By comparison ...

In this article, we are going to take a look at where Arvinas, Inc. (NASDAQ:ARVN) stands against other best small-cap stocks ...

On Tuesday, Arvinas Inc. ARVN and Pfizer Inc. PFE announced preliminary data from the ongoing Phase 1b portion of the TACTIVE-U sub-study of vepdegestrant in combination with abemaciclib for ...

In a report released today, Jonathan Miller from Evercore ISI maintained a Buy rating on Arvinas Holding Company (ARVN – Research Report), with a price target of $110.00. The company’s shares ...

Barclays analyst Peter Lawson maintained a Buy rating on Arvinas Holding Company (ARVN – Research Report) today and set a price target of $48.00. The company’s shares closed yesterday at $19.74.